Delivery Order SPE2DB20D1100-SPE2DB25FB8C7

Award Date 4/17/25
Potential Completion Date 4/18/25
Potential Value $9.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the medication Mounjaro (tirzepatide) 10 mg/0.5 ml pens. The contract is a firm fixed-price, non-set-aside delivery order with a ceiling value of $1,127.88 and a period of performance through April 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,035.35, is for the delivery of the medication Mounjaro (tirzepatide) 5 mg/0.5 ml pens. The contract is a Firm Fixed Price, non-set-aside award with a completion date of June 4, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,038.12, is for the supply of Mounjaro (tirzepatide) 10 mg/0.5 ml pens. It is a firm fixed-price, non-set-aside contract with a performance period through May 5, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,546.59, is for the delivery of the drug Mounjaro (tirzepatide) 10 mg/0.5 ml pens. The contract has a firm fixed price and has a completion date of June 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,290.18, is for the supply of the medication Mounjaro (tirzepatide) 5 mg/0.5 ml pen. It is a firm fixed-price delivery order contract with an ultimate completion date of April 16, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,410.08, is for the delivery of the prescription medication Mounjaro (tirzepatide) 10 mg/0.5 ml pens. The contract is a firm fixed-price delivery order with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the medication Mounjaro (tirzepatide) 10 mg/0.5 ml pen in 0.5 ml quantities. The contract has a ceiling value of $26,540.84 and a period of performance through May 1, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial...
This is a $7,950.20 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of the drug Mounjaro (tirzepatide) 5 mg/0.5 mL pen. There is no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,342.28 contract is for the supply of the drug Mounjaro (tirzepatide) 10 mg/0.5 ml pen. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mounjaro (tirzepatide) 7.5 mg/0.5 mL pens. The contract has a ceiling value of $22,988.50 and a period of performance through April 11, 2025. It is a firm-fixed-price contract, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FB8C7
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,926.53, is for the delivery of the prescription medication Mounjaro (tirzepatide) 5 mg/0.5 ml pen. It is a firm fixed-price contract with an ultimate completion date of April 18, 2025.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is likely part of that larger IDC, allowing AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The contract is not designated as a set-aside.

Generated 7/17/25, 2:37 PM